Trulieve Cannabis Corp. (NYSE:TRLV) Sees Significant Increase in Short Interest

Trulieve Cannabis Corp. (NYSE:TRLV) was the target of a large growth in short interest during the month of September. As of September 15th, there was short interest totaling 5,117,058 shares, a growth of 254.2% from the August 31st total of 1,444,593 shares. Currently, 2.8% of the shares of the company are short sold. Based on an average trading volume of 1,803,727 shares, the days-to-cover ratio is presently 2.8 days.

Analyst Ratings Changes

TRLV has been the subject of several analyst reports. Zacks Research upgraded Trulieve Cannabis to a “hold” rating in a research note on Thursday, June 18th. Wall Street Zen downgraded Trulieve Cannabis from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Cantor Fitzgerald reissued an “overweight” rating and set a $15.00 price target on shares of Trulieve Cannabis in a report on Friday, August 7th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Trulieve Cannabis in a research report on Friday, September 11th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Trulieve Cannabis presently has an average rating of “Hold” and a consensus price target of $15.00.

Trulieve Cannabis Trading Down 0.4%

Shares of NYSE:TRLV opened at $12.22 on Friday. Trulieve Cannabis has a 1-year low of $4.62 and a 1-year high of $13.28. The firm’s 50 day moving average price is $10.38.

Trulieve Cannabis (NYSE:TRLV) last posted its quarterly earnings results on Friday, August 7th. The company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.05. The firm had revenue of $271.00 million during the quarter, compared to the consensus estimate of $268.82 million. On average, equities research analysts predict that Trulieve Cannabis will post 0.31 EPS for the current fiscal year.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company that cultivates, processes, manufactures and sells medical and adult-use cannabis products. Its product portfolio includes flower, pre-rolls, concentrates, edibles, tinctures, capsules and topical products, marketed under the Trulieve brand and other affiliated brands.

The company sells its products through a network of company-operated dispensaries and, where permitted, through wholesale and other distribution channels.